Yayınlar & Eserler

Yayın Ağı
Makaleler 21
Tümü (21)
SCI-E, SSCI, AHCI (15)
SCI-E, SSCI, AHCI, ESCI (20)
ESCI (3)
Scopus (21)
TRDizin (11)

1. Shortening antibiotic therapy duration for hospital-acquired bloodstream infections in critically ill patients: a causal inference model from the international EUROBACT-2 database

Gajdos L., Buetti N., Tabah A., Ruckly S., AKOVA M., Sjöval F., et al.
Intensive Care Medicine , cilt.51, sa.3, ss.518-528, 2025 (SCI-Expanded, Scopus)

2. Effect of adequacy of empirical antibiotic therapy for hospital-acquired bloodstream infections on intensive care unit patient prognosis: a causal inference approach using data from the Eurobact2 study

Loiodice A., Bailly S., Buetti N., Barbier F., Staiquly Q., Tabah A., et al.
Clinical Microbiology and Infection , cilt.30, sa.12, ss.1559-1568, 2024 (SCI-Expanded, Scopus)

3. Presentation, management, and outcomes of older compared to younger adults with hospital-acquired bloodstream infections in the intensive care unit: a multicenter cohort study

Margalit I., Yahav D., Hoffman T., Tabah A., Barbier F., Singer P., et al.
Infection , cilt.52, sa.6, ss.2435-2443, 2024 (SCI-Expanded, Scopus)

4. The Efficacy of Glecaprevir/Pibrentasvir in Chronic Hepatitis C Patients and the Impact of the COVID-19 Pandemic: Multicenter Real-Life Data

GÜRBÜZ Y., Kocagül-çelikbaş A., ÖZTOPRAK ÇUVALCI N., AYGEN B., BATIREL A., Habiloğlu A. D., et al.
Infectious Diseases and Clinical Microbiology , cilt.6, sa.3, ss.216-224, 2024 (ESCI, Scopus, TRDizin) Creative Commons License

5. Epidemiology and risk factors of 28-day mortality of hospital-acquired bloodstream infection in Turkish intensive care units: a prospective observational cohort study

Aslan A. T., Tabah A., Köylü B., KAYA KALEM A., AKSOY F., Erol Ç., et al.
Journal of Antimicrobial Chemotherapy , cilt.78, sa.7, ss.1757-1768, 2023 (SCI-Expanded, Scopus)

6. Impact of COVID-19 pandemic on diagnosis and treatment access of patients with viral hepatitis in Turkey

ESER F., GÜNER H. R., GÜRBÜZ Y., Akdoǧan M., Bilgiç Z., Korkmaz N., et al.
Journal of Infection in Developing Countries , cilt.17, sa.4, ss.461-467, 2023 (SCI-Expanded, Scopus) Creative Commons License

7. Epidemiology and outcomes of hospital-acquired bloodstream infections in intensive care unit patients: the EUROBACT-2 international cohort study

Buetti N., Staiquly Q., Ruckly S., AKOVA M., Aslan A. T., Leone M., et al.
Intensive Care Medicine , cilt.49, sa.2, ss.178-190, 2023 (SCI-Expanded, Scopus)

8. Management of Chronic Hepatitis C Virus Infection: A Consensus Report of the Study Group for Viral Hepatitis of the Turkish Society of Clinical Microbiology and Infectious Diseases-2023 Update Kronik Hepatit C Virusu İnfeksiyonunun Yönetimi: Türk Klinik Mikrobiyoloji ve İnfeksiyon Hastalıkları Derneği Viral Hepatit Çalışma Grubu Uzlaşı Raporu-2023 Güncellemesi

AYGEN B., GÜRBÜZ Y., Çetinkaya R. A., ÇINAR G., KAYABAŞ Ü., Örmen B., et al.
Klimik Dergisi , cilt.36, ss.43-75, 2023 (ESCI, Scopus, TRDizin) Creative Commons License

9. Demographic Characteristics and Transmission Risk Factors of Patients with Hepatitis C Virus in Turkey: The EPI-C, A Multicenter and Cross-sectional Trial Türkiye’de Hepatit C Hastalarının Demografik Karakteristikleri ve Bulaşma Risk Faktörleri: Çok Merkezli ve Kesitsel EPI-C Çalışması

Tabak F., ŞİRİN G., DEMİR M., Aladağ M., Sümer Ş., Kurtaran B., et al.
Viral Hepatitis Journal , cilt.27, sa.3, ss.109-117, 2021 (ESCI, Scopus, TRDizin)

10. Real-world data from Turkey: Is sofosbuvir/ledipasvir with or without ribavirin treatment for chronic hepatitis C really effective?

Demirtürk N., AYGEN B., ÇELİK İ., Mıstık R., AKHAN S., BARUT H. Ş., et al.
Turkish Journal of Gastroenterology , cilt.32, sa.2, ss.155-163, 2021 (SCI-Expanded, Scopus, TRDizin)

11. Real-world efficacy, safety, and clinical outcomes of ombitasvir/paritaprevir/ritonavir ± dasabuvir ± ribavirin combination therapy in patients with hepatitis C virus genotype 1 or 4 infection: The Turkey experience experience

AYGEN B., Demirtürk N., YILDIZ O., Çelen M. K., Çelik İ., BARUT H. Ş., et al.
Turkish Journal of Gastroenterology , cilt.31, sa.4, ss.305-317, 2020 (SCI-Expanded, Scopus, TRDizin)

12. Evaluation of the seroprevalence of viral hepatitis and the human immunodeficiency virus among hospital workers in Turkey and the Turkish Republic of Northern Cyprus

Kalkan I. A., ÇINAR G., Mut A. N. U., KARAŞAHİN Ö., GÜRBÜZ Y., Tekin A., et al.
Hepatitis Monthly , cilt.20, sa.4, 2020 (SCI-Expanded, Scopus)

13. Predicting diabetic foot ulcer infection using the neutrophil-to-lymphocyte ratio: A prospective study

Altay F. A., Kuzi S., ALTAY M., ATEŞ İ., GÜRBÜZ Y., Ediz Tütüncü E., et al.
Journal of Wound Care , cilt.28, sa.9, ss.601-607, 2019 (SCI-Expanded, Scopus)

14. Reactivation rates in patients using biological agents, with resolved HBV infection or isolated anti-HBc IgG positivity

Solay A. H., Acar A., ESER F., KUŞCU F., TÜTÜNCÜ E. E., Kul G., et al.
Turkish Journal of Gastroenterology , cilt.29, sa.5, ss.561-565, 2018 (SCI-Expanded, Scopus, TRDizin)

15. Adherence to nucleoside/nucleotide analogue treatment in patients with chronic hepatitis B

TÜTÜNCÜ E. E., GÜNER H. R., GÜRBÜZ Y., KAYA KALEM A., Öztürk B., Hasanoğlu İ., et al.
Balkan Medical Journal , cilt.34, sa.6, ss.540-545, 2017 (SCI-Expanded, Scopus, TRDizin)

16. Evaluation of patients diagnosed with severe acute respiratory tract infection: 2015-2016 influenza season Ağır akut solunum yolu infeksiyonuyla izlenen hastaların değerlendirilmesi: 2015-2016 influenza sezonu

ESER F., TÜTÜNCÜ E. E., Haykır-Solay A., Altın N., Çiçek-Şentürk G., Altay F. A., et al.
Klimik Dergisi , cilt.30, sa.3, ss.114-119, 2017 (Scopus, TRDizin)

17. Management of chronic hepatitis C virus infection: A consensus report of the study group for viral hepatitis of the Turkish society of clinical microbiology and infectious diseases-2017 update Kronik hepatit C virusu infeksiyonunun yönetimi: Türk klinik mikrobiyoloji ve infeksiyon hastaliklari derneği viral hepatit çalişma grubu uzlaşi raporu-2017 güncellemesi

AYGEN B., Demirtürk N., Türker N., ASAN A., Eraksoy H., GÜRBÜZ Y., et al.
Klimik Dergisi , cilt.30, sa.Special Issue 1, ss.2-35, 2017 (Scopus, TRDizin)

18. Evaluation of dual therapy in real life setting in treatment-naïve Turkish patients with HCV infection: A multicenter, retrospective study

GÜRBÜZ Y., Tülek N. E., TÜTÜNCÜ E. E., Koruk S. T., AYGEN B., Demirtürk N., et al.
Balkan Medical Journal , cilt.33, sa.1, ss.18-26, 2016 (SCI-Expanded, Scopus, TRDizin)

19. Surgical site infection rates in 16 cities in Turkey: findings of the International Nosocomial Infection Control Consortium (INICC)

Leblebicioglu H., ERBEN N., Rosenthal V. D., Sener A., UZUN C., Senol G., et al.
American Journal of Infection Control , cilt.43, sa.1, ss.48-52, 2015 (SCI-Expanded, Scopus)

20. A water-borne tularemia outbreak caused by francisella tularensis subspecies halorctica in central Anatolia Region İç anadolu bölgesinde francisella tularensis alt tür halorctica'ya bag̀li su kaynakli bir tularemi salgini

Ayşegül Kiliç U., KILIÇ S., Şencan I., Şentürk G. Ç., GÜRBÜZ Y., TÜTÜNCÜ E. E., et al.
Mikrobiyoloji Bulteni , cilt.45, sa.2, ss.234-247, 2011 (SCI-Expanded, Scopus, TRDizin)

21. Two tularemia cases with atypical presentation Atipik bulgularla seyreden i̇ki tularemi olgusu

Ulu-Kiliç A., Çiçek-Şentürk G., TÜTÜNCÜ E. E., KILIÇ S., Altay F. A., GÜRBÜZ Y., et al.
Klimik Dergisi , cilt.23, sa.3, ss.120-123, 2010 (Scopus)
Metrikler

Yayın

21

Yayın (WoS)

20

Yayın (Scopus)

21

H-İndeks (WoS)

9

Atıf (Scopus)

464

H-İndeks (Scopus)

10

Atıf (TrDizin)

13

H-İndeks (TrDizin)

3

Atıf (Diğer Toplam)

13

Tez Danışmanlığı

4

Açık Erişim

5